The t(15;17)(q24;q21) translocation is a characteristic lesion of acute promyelocytic leukemia (APL),
accounting for approximately 9% of all acute myeloid leukemia (AML) cases. Treatment with all-trans retinoic acid combined with arsenic trioxide yields a favorable prognosis.